File #: 24-0688    Version: 1 Name: Settlement: Special Initiatives for High-Risk Populations
Type: Manager's Report Status: Manager’s Report
File created: 11/21/2024 In control: County Manager's Office
On agenda: 12/3/2024 Final action:
Title: Opioid Settlement: Special Initiatives for High-Risk Populations
Attachments: 1. Opioid Settlements Updates - MAT and PORT Request- updated V5, 2. Board Resolution on Expanded Opioid Spending Plan - 12.3.24 Updated 11.pdf
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.

 

Title

Opioid Settlement: Special Initiatives for High-Risk Populations

 

Action

ACTION:

(1) Recognize, receive and appropriate $5.5 Million in Opioid Settlement funds from Wave 2 funding to the Opioid Settlement Special Revenue Fund (OPIS).

 

(2) Adopt the resolution entitled “Resolution of the Mecklenburg County Board of Commissioners Directing $5.5 Million in Second Round Opioid Settlement Fund Expenditures for High-Risk Populations.

 

 

 

Staff Contact:                           Dena Diorio, County Manager

                                                               Marcus Boyd, Behavioral Health Program Manager                                                

                                                               Tyrone C. Wade, County Attorney

 

 

 

Presentation:      Yes                                             

 

 

BACKGROUND/JUSTIFICATION:

Mecklenburg County joined the national settlement Memorandum of Agreement between the State of North Carolina and Local Governments outlining the distribution of any proceeds relating to the settlement of opioid litigation, and any subsequent settlement funds that may come into North Carolina as a result of the opioid  litigation against  companies engaged in the manufacturing, distribution, and dispensing of opioids, including settlements with drug distributors Cardinal, McKesson, and AmerisourceBergen, and the drug maker Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, referred to as Wave 1 of the Opioid Settlement. Wave 2 Additional Settlements with Additional Settling Defendants Walmart, Inc., Teva Pharmaceutical Industries Ltd., Allergan Finance, LLC, Allergan Limited, CVS Health Corporation, CVS Pharmacy, Inc., and Walgreen Co., as well as their subsidiaries, affiliates, officers, and directors named in the Additional Settlements and the Kroger Settlement will be disbursed to Mecklenburg County as well.

As part of the Opioid Settlement, Mecklenburg County will receive $74,854,434 over a sixteen-year period from 2022 and 2038. Pursuant to the NC Memorandum of Agreement (which provides policy guidance for use of the funds), Mecklenburg County is utilizing Exhibit A strategies to address the opioid overdose epidemic.

The recommendations and existing investments have been informed by insights from multiple opioid settlement community meetings, input from the Substance Use Disorder Task Force, best practice research, and dialogue with local advocates, subject matter experts and many other stakeholders. 

For the second round of Opioid Settlement investments, three new Exhibit A strategies are recommended to focus on high-risk populations both in the community and in the Mecklenburg County Detention Center:

                     Post Overdose Response Team

                     Addiction Treatment for Incarcerated Persons

                     Reentry Programs

 

For the second round of investments, it is also recommended to increase funding to the following strategy area to ensure availability of the overdose reversal medication in Mecklenburg County:

 

                     Naloxone Distribution

 

 

PROCUREMENT BACKGROUND:

N/A

 

 

POLICY IMPACT:

N/A

 

 

FISCAL IMPACT:

$5.5 Million increase in Opioid Settlement Special Revenue Fund (OPIS) revenue and associated expenses.